Hot Investor Mandate 2: Asia-Based PE Firm Seeks Disruptive Healthcare Technologies at the Clinical or Growth Stage

2 Mar

A private equity firm based in Beijing, China specializes in growth capital and buy-out investment. The firm focuses on growing Chinese and Western companies in several sectors including healthcare that benefit from China’s growing consumption population. The firm invests north of US$20 million in companies in Series B, C, or above. The firm considers opportunities from China as well as overseas deals with a China angle.

Within healthcare, the firm is looking for cutting-edge technologies in biopharmaceuticals, medical devices, diagnostics, and technology platform. The firm typically prefers mature companies. However, the firm is also interested in pre-revenue companies with disruptive technologies that address large unmet needs.

The firm is seeking experienced management teams with strong sector knowledge. The firm may request board representation post-investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: